Preoperative and postoperative chemotherapy for nonmetastatic osteosarcoma of the extremities in children;Tratamiento del sarcoma osteogenico de extremidades en la infancia con quimioterapia pre y postoperatoria

Medicina Clinica

Volumn 107, Issue 5, 1996, Pages 161-164

  Muñoz Villa, Arturo ^a,b   Ocete, Guillermo ^a   Aymerich, María Luisa ^a   Maldonado, Soledad ^a   Otheo, Enrique ^a   Calvo, Miguel ^a   Amaya, Jaime ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; METHOTREXATE; VINCRISTINE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; ANTINEOPLASTIC ANTIMETABOLITE;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; FEMALE; HISTOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIMB; MALE; METASTASIS; OSTEOSARCOMA; AGE; BONE TUMOR; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FOLLOW UP; MORTALITY; MULTIVARIATE ANALYSIS; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRESCHOOL CHILD; SURVIVAL RATE; TIME;

ADOLESCENT; AGE FACTORS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; CISPLATIN; DISEASE-FREE SURVIVAL; DOXORUBICIN; EXTREMITIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METHOTREXATE; MULTIVARIATE ANALYSIS; OSTEOSARCOMA; POSTOPERATIVE CARE; PREOPERATIVE CARE; SURVIVAL RATE; TIME FACTORS; VINCRISTINE;

EID: 0030605691     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Dix D, Mc Donald M, Cohen P. Adolescent bone cancer: is the growth spurt implicates? Eur J Cancer 1983; 19: 859-860.
2. Registro Nacional de tumores infantiles. Estadísticas básicas (1980-1990). Valencia: Monografías de la Consejerla de Sanidad y Consumo de la Generalidad Valenciana, 1992.
3. Meyers PA, Meller G, Healey JH, Huvos A, Applewhite A, Sun M et al. Osteogenic sarcoma with detectable metastasis at initial presentation. J Clin Oncol 1993; 11: 449-453.
4. Friedman MA, Carter SK. The therapy of osteogenic sarcoma: current status and thoughts for the future. J Surg Oncol 1972; 4: 482-510.
5. Jaffe N, Frei E, Traggis D, Bishop Y. Adjuvant methotrexate and citrovorum factor treatment of osteogenic sarcoma. N Engl J Med 1974; 291: 994-997.
6. Cortes EP, Holland JF, Eang JJ. Amputation and adriamicin in primary osteosarcoma. N Engl J Med 1974; 292: 998-1.000.
7. Sutow WW, Gehan EA, Vietti TJ. Multidrug chemotherapy in primary treatment of osteosarcoma. Am J Bone Joint Surg 1976; 58: 629-633.
8. Link MP, Goozin AM, Miser A. The effect of adjuvant chemotherapy on relapse free survival in patient with osteosarcoma of the extremity. N Engl J Med 1986; 314: 1.600-1.606.
9. Rosen G, Caparros B, Huvos AG. Preoperative chemotherapy for osteogenic sarcoma selection of postoperative adjuvant chemotherapy based on the response of the primary tumor for preoperative chemotherapy. Cancer 1982; 49: 1.221-1.230.
10. Meyers PA, Meller G, Healey J, Huvos A, Lane J, Marcove R et al. Chemotherapy for non metastatic osteogenic sarcoma: the Memorial Sloan-Kettering Experience. J Clin Oncol 1992; 19: 5-15.
11. a ed.). Boston: Brown Co., 1986.
12. Provisor A, Nachman J, Krailo M, Ertel E, Makley J. Treatment of non metastatic osteogenic sarcoma of the extremities with pre and postoperative chemotherapy. Proc Am Soc Clin Oncol 1987; 6: 217.
13. Enneking WF, Spanier S, Goodman MA. The surgical staging of musculoskeletal sarcoma. J Bone Joint Surg 1980; 62A: 1.027-1.030.
14. Kalifa C, Mlika N, Dubousser J. The experience of the T-10 protocol in the pediatric department of the Gustave Roussy Institute. En: Ryan S, Baker L, editores, Recent concepts in sarcoma treatment. Boston: Kubler Academic Publishers, 1988; 301-305.
15. Weiner MA, Harris MB, Lewis M. Neoadjuvant high-dose methotrexate, cisplatin, doxorubicin for the management of patients with non-metastatic osteosarcoma. Cancer Treat Rep 1986; 70: 1.431-1.432.
16. Bacci G, Picci P, Ruggieri P. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. Cancer 1990; 65: 2.539-2.553.
17. Winkler K, Bieling P, Bielac S, Delling G, Dose C, Jurgen H. Local control and survival from the cooperative osteosarcoma study group studies of the German Society of Pediatric Oncology and the Vienna Bone Tumor Orthop Registry. Clin Orthop 1991; 270: 79-86.
18. Rosen G, Nieremberg A. Chemotherapy for osteogenic sarcoma: an investigative method, not a recipe. Cancer Treat Rep 1982; 66: 1.687-1.697.
19. Bramwell V, Burgers M, Sneath R, Souhami R, Von Oosteron A, Voute P. A comparison of two intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup. J Clin Oncol 1992; 10; 1.578-1.591.
20. Davis A, Bell R, Goodwin P. Prognostic factors in osteosarcoma: a critical review. J Clin Oncol 1994; 12: 423-431.
21. Bacci G, Picci P, Ferrari S, Ruggieri P, Casadei R, Tienghi A. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Cancer 1993; 72: 3.227-3.238.
22. Miser J, Arndt C, Smithson W, Gilchrist G, Edmonson J, Sim F. Treatment of high-grade osteosarcoma with ifosfamide, mesna, adriamicin, high-dose methotrexate with o without cisplatin. Results of two pilots trials. Proc Am Soc Clin Oncol 1994; 13: 1.443.
23. Harris M, Cantor A, Goorin A, Shochat S, Ayala A, Ferguson J et al. Treatment of osteosarcoma with ifosfamide: comparison of response in pediatric patients with recurrent disease versus patients previously untreated: a Pediatric Oncology Group Study. Med Pediatr Oncol 1995; 24: 87-92.